Multicentre international liver tumour study protocol of the case-control study on hepatocellular cancer

Pharmacoepidemiology and Drug Safety

Volumn 5, Issue 3, 1996, Pages 173-186

  Heinemann, L A J ^a   Thomas, D B ^b   Mohner M ^b  

^a ZEG   (Germany)

^b NONE

Author keywords

Case control study; Cyproterone acetate; Epidemiology; Liver cancer; Oral contraceptives; Pharmacoepidemiology

Indexed keywords

CYPROTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ARTICLE; CANCER RISK; CLINICAL PROTOCOL; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; METHODOLOGY; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0029952392     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199605)5:3<173::AID-PDS224>3.0.CO;2-R     Document Type: Article

References (16)

1. Neumann, I., Thierau, D., Andrae, U., Greim, H. and Schwarz, L. R. Cyproterone acetate induces DNA damage in cultured rat hepatocytes and preferentially stimulates DNA synthesis in γ-glutamyl-transpeptidase-positive cells. Carcinogeneses 1992; 13: 373-378.
2. Topinka, J., Andrae, U., Schwarz, L. R., Werner, S., Schramm, R. J. and Wolff, T. Persistence and accumulation of DNA adducts by the synthetic steroid cyproterone acetate in rat liver in vivo. 23rd Annual Meeting of the European Environmental Mutagen Society (EEMS) in Barcelona, 27 September-2 October 1993 (poster).
3. Marelli, A., Glua, M., Mattioli, F., Mereto, E. and Andrae, U. Experimental evidence for a carcinogenic risk of cyproterone acetate to humans. Congresso Nationale di Farmacologie in Turin, 5-6 September 1994 (poster).
4. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Combined oral contraceptives and liver cancer. International Journal of Cancer 1989; 43: 254-259.
5. Thomas, D. B. Exogenous steroid hormones and hepatocellular carcinoma. In: Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. Advances in Applied Biotechnology Series, Vol. 13. Tabor, E., Di Bisceglie, A. M. and Purcell, R. H. (Eds), Gulf Printing Co., Houston, 1991, pp. 77-89.
6. Prentice, R. L. Epidemiologic data on exogenous hormones and hepatocellular carcinoma and selected other cancers. Preventive Medicine 1991; 20: 38-46.
7. Henderson, B. E., Preston-Martin, S., Edmondson, H. A., Peters, R. L. and Pike, M. C. Hepatocellular carcinoma and oral contraceptives. British Journal of Cancer 1983; 48: 437-440.
8. Neuberger, J., Forman, D., Doll, R. and Williams, R. Oral contraceptives and hepatocellular carcinoma. British Medical Journal 1986; 292: 1355-1357.
9. Forman, D., Vincent, T. J. and Doll, R. Cancer of the liver and the use of oral contraceptives. British Medical Journal 1986; 292: 1357-1361.
10. La Vecchia, C., Negri, E. and Parazzini, F. Oral contraceptives and primary liver cancer. British Journal of Cancer 1989; 59: 460-461.
11. Palmer, J. R., Rosenberg, L., Kaufmann, D. W., Warshauer, M. E., Stolley, P. and Shapiro, S. Oral contraceptive use and liver cancer. American Journal of Epidemiology 1989; 130: 878-882.
12. Kew, M. C., Song, E., Mohammed, A. and Hodkinson, J. Contraceptive steroids as a risk factor for hepatocellular carcinoma: A case/control study in South African black women. Hepatology 1990; 11: 298-302.
13. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Depot-medroxyprogesterone acetate (DMPA) and risk of liver cancer. International Journal of Cancer 1991; 49: 182-185.
14. Hsing, A. W., Hoover, R. N., McLaughlin, J. K. et al. Oral contraceptives and primary liver cancer among young women. Cancer Causes Control 1992; 3: 43-48.
15. Tavani, A., Negri, E., Parazzini, F., Franceschi, S. and LaVecchia, C. Female hormone utilisation and risk of hepatocellular carcinoma. British Journal of Cancer 1993; 67: 635-637.
16. The World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraceptives. Reliability of data from proxy respondents in a case-control study of cardiovascular diseases and oral contraceptives use. International Journal of Epidemiology. Submitted for publication.